Issue 20, 2024

A hetero-bimetallic Ru(ii)–Ir(iii) photosensitizer for effective cancer photodynamic therapy under hypoxia

Abstract

A hetero-bimetallic Ru(II)–Ir(III) photosensitizer was developed. Upon light exposure, contrary to the homogeneous Ru(II)–Ru(II) and Ir(III)–Ir(III) complexes that can only produce singlet oxygen, Ru(II)–Ir(III) can generate multiple reactive oxygen species and kill hypoxic tumors. This study presents the first example of a hetero-bimetallic type-I and type-II dual photosensitizer.

Graphical abstract: A hetero-bimetallic Ru(ii)–Ir(iii) photosensitizer for effective cancer photodynamic therapy under hypoxia

Supplementary files

Article information

Article type
Communication
Submitted
06 Jan 2024
Accepted
09 Feb 2024
First published
10 Feb 2024

Chem. Commun., 2024,60, 2776-2779

A hetero-bimetallic Ru(II)–Ir(III) photosensitizer for effective cancer photodynamic therapy under hypoxia

M. Zheng, X. Lin, K. Xiong, X. Zhang, Y. Chen, L. Ji and H. Chao, Chem. Commun., 2024, 60, 2776 DOI: 10.1039/D4CC00072B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements